Cancer IQ Revenue and Competitors
Estimated Revenue & Valuation
- Cancer IQ's estimated annual revenue is currently $6.8M per year.
- Cancer IQ's estimated revenue per employee is $126,000
Employee Data
- Cancer IQ has 54 Employees.
- Cancer IQ grew their employee count by -8% last year.
Cancer IQ's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | CTO | Reveal Email/Phone |
3 | CFO | Reveal Email/Phone |
4 | VP Product | Reveal Email/Phone |
5 | VP Customer Success | Reveal Email/Phone |
6 | VP Sales | Reveal Email/Phone |
7 | SVP, Commercial Strategy | Reveal Email/Phone |
8 | Head People and Operations | Reveal Email/Phone |
9 | VP, Sales | Reveal Email/Phone |
10 | VP Sales | Reveal Email/Phone |
Cancer IQ Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.9M | 55 | -4% | N/A | N/A |
#2 | $0.6M | 8 | -20% | N/A | N/A |
#3 | $5470M | 11026 | 4% | $2B | N/A |
#4 | $0.5M | 16 | -16% | $15M | N/A |
#5 | $1M | 12 | -8% | N/A | N/A |
#6 | $6.7M | 53 | 4% | N/A | N/A |
#7 | $1.3M | 16 | -11% | N/A | N/A |
#8 | $58.1M | 332 | -20% | N/A | N/A |
#9 | $3087.2M | 15751 | 6% | N/A | N/A |
#10 | $3.7M | 35 | -12% | $1.4M | N/A |
What Is Cancer IQ?
About Us CancerIQ helps providers use genetic information to predict, pre-empt, and prevent disease - starting with cancer. By making is easier to identify patients at risk, offer a genetic evaluation at point of care, and design a tailored cancer prevention plan - we can help healthcare systems get ahead of this costly and emotionally devastating disease. Why Work with Us? We have quietly built a market-leading product that patients, providers, and healthcare executives all love. With new funding and new strategic partners, we're on pace for rapid growth. We've a team of clever, scrappy, and mission-driven individuals making a huge impact in cancer prevention - so if you're passionate about healthcare - join our team.
keywords:N/AN/A
Total Funding
54
Number of Employees
$6.8M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cancer IQ News
Ballard consulted with Michele Settelmyer, an advanced practice registered nurse with OSF HealthCare and a CancerIQ champion specializing in...
Social Determinants of Health (SDOH) Market to Reflect Steadfast Expansion During 2022-2029 | Arcadia Group, Cancer IQ, Cerner, Color, Optum.
IQ-AI subsidiary Imaging Biometrics CEO Michael Schmainda shares the latest progress on the group has made on its Phase I brain cancer...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.8M | 54 | 10% | N/A |
#2 | $7M | 54 | 8% | N/A |
#3 | $10.2M | 54 | 50% | N/A |
#4 | $5M | 54 | 23% | N/A |
#5 | $6.8M | 54 | 2% | $36.1M |